Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sputnik Light COVID-19 vaccine trial
PACTR202104601572565Phase 3Not yet recruiting
- Sponsor
- Joi Human Vaccine
- Start
- May 2021
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of rAd26 in coronavirus disease 2019 (COVID-19), sponsored by Joi Human Vaccine. Primary endpoints: Active COVID-19 after vaccination, Local and systemic reactogenicity and 1 more. Planned start May 2021; status: not yet recruiting.
02
Drugs
rAd26
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202104601572565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202104601572565.